Clinical Trial Update: To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial assessed the safety and preliminary efficacy of combining CD25 targeting with low-dose cyclosporin in active psoriasis vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CD25
• Cyclosporin (cyclosporine)

Snippet

Sponsor: Rockefeller University | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED